157 related articles for article (PubMed ID: 38892595)
1. Does Magnesium Provide a Protective Effect in Crohn's Disease Remission? A Systematic Review of the Literature.
Costescu S; Bratosin F; Popa ZL; Hrubaru I; Citu C
Nutrients; 2024 May; 16(11):. PubMed ID: 38892595
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
4. Stem cell transplantation for induction of remission in medically refractory Crohn's disease.
El-Nakeep S; Shawky A; Abbas SF; Abdel Latif O
Cochrane Database Syst Rev; 2022 May; 5(5):CD013070. PubMed ID: 35556242
[TBL] [Abstract][Full Text] [Related]
5. Enteral nutritional therapy for induction of remission in Crohn's disease.
Zachos M; Tondeur M; Griffiths AM
Cochrane Database Syst Rev; 2007 Jan; (1):CD000542. PubMed ID: 17253452
[TBL] [Abstract][Full Text] [Related]
6. Active Crohn's disease is associated with low vitamin D levels.
Jørgensen SP; Hvas CL; Agnholt J; Christensen LA; Heickendorff L; Dahlerup JF
J Crohns Colitis; 2013 Nov; 7(10):e407-13. PubMed ID: 23403039
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Taylor K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine for induction of remission in Crohn's disease.
McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
[TBL] [Abstract][Full Text] [Related]
9. Glutamine for induction of remission in Crohn's disease.
Akobeng AK; Elawad M; Gordon M
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD007348. PubMed ID: 26853855
[TBL] [Abstract][Full Text] [Related]
10. Low dose naltrexone for induction of remission in Crohn's disease.
Parker CE; Nguyen TM; Segal D; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010410. PubMed ID: 29607497
[TBL] [Abstract][Full Text] [Related]
11. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Wang Y; MacDonald JK; Hanauer S
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
[TBL] [Abstract][Full Text] [Related]
12. The effects and predictive value of calcium and magnesium concentrations on nutritional improvement, inflammatory response and diagnosis in patients with Crohn's disease.
Zheng Y; Liao Y; Ouyang Y; Wu Z; Li Z; Lin J; Zhang K; Wang X; Cen Z; Ma W; Dai S
J Hum Nutr Diet; 2023 Oct; 36(5):1649-1660. PubMed ID: 37485801
[TBL] [Abstract][Full Text] [Related]
13. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
Boyapati RK; Torres J; Palmela C; Parker CE; Silverberg OM; Upadhyaya SD; Nguyen TM; Colombel JF
Cochrane Database Syst Rev; 2018 May; 5(5):CD012540. PubMed ID: 29756637
[TBL] [Abstract][Full Text] [Related]
14. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
[TBL] [Abstract][Full Text] [Related]
15. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.
Limketkai BN; Iheozor-Ejiofor Z; Gjuladin-Hellon T; Parian A; Matarese LE; Bracewell K; MacDonald JK; Gordon M; Mullin GE
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012839. PubMed ID: 30736095
[TBL] [Abstract][Full Text] [Related]
16. Enteral nutritional therapy for induction of remission in Crohn's disease.
Narula N; Dhillon A; Zhang D; Sherlock ME; Tondeur M; Zachos M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000542. PubMed ID: 29607496
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
Zhou S; Huang Z; Hou W; Lin Y; Yu J
Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
[TBL] [Abstract][Full Text] [Related]
18. Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].
von Martels JZH; Bourgonje AR; Klaassen MAY; Alkhalifah HAA; Sadaghian Sadabad M; Vich Vila A; Gacesa R; Gabriëls RY; Steinert RE; Jansen BH; Bulthuis MLC; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; de Vos P; van Goor H; Faber KN; Harmsen HJM; Dijkstra G
J Crohns Colitis; 2020 Jun; 14(5):595-607. PubMed ID: 31873717
[TBL] [Abstract][Full Text] [Related]
19. Low dose naltrexone for induction of remission in Crohn's disease.
Segal D; Macdonald JK; Chande N
Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
[TBL] [Abstract][Full Text] [Related]
20. Hypocalcemia secondary to hypomagnesemia in a patient with Crohn's disease.
Mukai A; Yamamoto S; Matsumura K
Clin J Gastroenterol; 2015 Feb; 8(1):22-5. PubMed ID: 25475137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
